title: Ulcerations on abdominal wound scar associated with aflibercept therapy.
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: Nancy
authors.initials: N
authors.lastname: Rivas-Tolosa
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Calomarde
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: Bernardo
authors.initials: B
authors.lastname: Bancalari
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: Guillén
authors.affiliation: Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
authors.forename: Onofre
authors.initials: O
authors.lastname: Sanmartín
mesh_terms: D000005:Abdomen; D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D001458:Bandages; D002921:Cicatrix / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D012075:Remission, Spontaneous; D012883:Skin Ulcer / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D028761:Withholding Treatment
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor